How do IDH2 mutations contribute to Cancer development?
The mutant IDH2 enzyme produces 2-HG, which interferes with normal cellular metabolism and epigenetic regulation. This oncometabolite inhibits enzymes involved in DNA and histone demethylation, leading to widespread changes in gene expression. Ultimately, these alterations contribute to the initiation and progression of cancer by affecting cell differentiation and proliferation.
